FibroBiologics FBLG
NASDAQ FBLG
$1.02 +0.02 (+2.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

FibroBiologics (FBLG) Short term Debt (2026)

Updated

FibroBiologics' Short term Debt came in at $124,000 for Q2 2026, down 49.6% from the prior quarter.

Analysis

FibroBiologics (FBLG) Short term Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 FibroBiologics 6.40 Mn -8.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124,000.00
Mar 31, 2026 246,000.00
API Access

FibroBiologics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=FBLG&period=max&api_key=YOUR_API_KEY